BMO Capital Maintains Market Perform on Ingevity, Lowers Price Target to $42
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst John McNulty maintains a Market Perform rating on Ingevity (NYSE:NGVT) but lowers the price target from $45 to $42.
August 05, 2024 | 2:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BMO Capital analyst John McNulty maintains a Market Perform rating on Ingevity but lowers the price target from $45 to $42.
The lowered price target from $45 to $42 suggests a less optimistic outlook for Ingevity's stock performance. This could lead to a short-term negative impact on the stock price as investors may adjust their expectations accordingly.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100